Advanced search
Publication Cover
International Journal of Radiation Biology Volume 96, 2020 - Issue 9
Submit an article Journal homepage
234
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Induction of different cellular arrest and molecular responses in low EGFR expressing A549 and high EGFR expressing A431 tumor cells treated with various doses of 177Lu-Nimotuzumab

ShishuKant Sumana Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, IndiaView further author information
,
Rashmi Priyab Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, IndiaView further author information
&
Mythili Kameswarana Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2999-6302View further author information
ORCID Icon
Pages 1144-1156 | Received 20 Sep 2019, Accepted 01 Jun 2020, Published online: 23 Jul 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

B.Y. Cai, T.S. Zhao, D.G. Qin & G.G. Tu. (2023) Synthesis, antiproliferative and 4D-QSAR studies of thiadiazole derivatives bearing acrylamide moiety as EGFR inhibitors. SAR and QSAR in Environmental Research 34:4, pages 341-359.
Read now

Articles from other publishers (3)

Mohammad Anisuzzman, Varsha Komalla, Mariam Abdulaziz M. Tarkistani & Veysel Kayser. (2023) Anti-Tumor Activity of Novel Nimotuzumab-Functionalized Gold Nanoparticles as a Potential Immunotherapeutic Agent against Skin and Lung Cancers. Journal of Functional Biomaterials 14:8, pages 407.
Crossref
Jean-Pierre Pouget, Marion Tardieu & Sophie Poty. 2023. Radiopharmaceutical Therapy. Radiopharmaceutical Therapy 91 122 .
Wei Liu, Kehong Li, Hao Deng, Jing Wang, Peng Zhao, Wei Liao, Liangang Zhuo, Hongyuan Wei, Xia Yang & Yue Chen. (2022) In vitro and in vivo evaluation of a novel anti-EGFR antibody labeled with 89Zr and 177Lu. Journal of Radioanalytical and Nuclear Chemistry 331:2, pages 747-754.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.